SCCM Pod-400 Are AKI Biomarkers Ready for Clinical Use?
Kyle B. Enfield, MD, FCCM, and Azra Bihorac, MD, MS, FCCM, discuss best practices and complexities of implementing biomarkers for kidney stress and acute kidney injury (AKI) and what the future holds for AKI biomarker literature.
AKI, Biomarkers, Stress
SCCM Pod-404 Population-Based Epidemiology and Outcomes of Acute Kidney Injury in Critically Ill Children
Margaret M. Parker, MD, MCCM, speaks with Rashid Alobaidi, MD, on his article titled "Population-Based Epidemiology and Outcomes of Acute Kidney Injury in Critically Ill Children,"
AKI, Monitoring, Pediatrics
SCCM Pod-405 Acute Kidney Injury Biomarkers and the Challenges of Clinical Use
Ludwig H. Lin, MD, and Michael G.S. Shashaty, MD, MS, discuss acute kidney injury (AKI) biomarkers and whether they are ready for clinical use.
SCCM Pod-VCCR10 Pathophysiology and Management of AKI
Richard Iuorio, MD, speaks with Kianoush Kashani, MD and Jim Reilly, MD about the pathophysiology and management of acute kidney injury.
AKI, Hypertension, Renal, Resuscitation, Sepsis